The Shell Asset Management Co. Lowers Stake in CVS Health Corp (CVS)

The Shell Asset Management Co. Lowers Stake in CVS Health Corp (CVS)

Several other institutional investors have also added to or reduced their stakes in the stock. Whittier Trust Co. boosted its position in CVS Health Corp by 1.9% in the third quarter. Whittier Trust Co. now owns 158,077 shares of the pharmacy operator’s stock valued at $14,067,000 after buying an additional 2,975 shares during the period. Acrospire Investment Management LLC boosted its position in CVS Health Corp by 178.2% in the third quarter. Acrospire Investment Management LLC now owns 2,966 shares of the pharmacy operator’s stock valued at $264,000 after buying an additional 1,900 shares during the period. Parkside Financial Bank & Trust boosted its position in CVS Health Corp by 3.0% in the third quarter. Parkside Financial Bank & Trust now owns 2,846 shares of the pharmacy operator’s stock valued at $254,000 after buying an additional 83 shares during the period. Carret Asset Management LLC boosted its position in CVS Health Corp by 2.5% in the third quarter. Carret Asset Management LLC now owns 89,141 shares of the pharmacy operator’s stock valued at $7,933,000 after buying an additional 2,175 shares during the period. Finally, Northern Trust Corp boosted its position in CVS Health Corp by 1.9% in the third quarter. Northern Trust Corp now owns 14,838,468 shares of the pharmacy operator’s stock valued at $1,320,476,000 after buying an additional 277,497 shares during the period. Institutional investors and hedge funds own 81.29% of the company’s stock.

Shell Asset Management Co. lowered its stake in shares of CVS Health Corp (NYSE:CVS) by 3.0% during the first quarter, Holdings Channel reports. The firm owned 99,218 shares of the pharmacy operator’s stock after selling 3,047 shares during the period. Shell Asset Management Co.’s holdings in CVS Health Corp were worth $7,789,000 at the end of the most recent reporting period.

Shares of CVS Health Corp (NYSE CVS) opened at 79.05 on Monday. The firm has a 50 day moving average price of $79.23 and a 200 day moving average price of $79.01. CVS Health Corp has a 52 week low of $69.30 and a 52 week high of $98.67. The company has a market capitalization of $80.54 billion, a price-to-earnings ratio of 16.49 and a beta of 0.85.

CVS Health Corp (NYSE:CVS) last released its quarterly earnings results on Tuesday, May 2nd. The pharmacy operator reported $1.17 earnings per share for the quarter, beating the consensus estimate of $1.10 by $0.07. The firm had revenue of $44.51 billion for the quarter, compared to analysts’ expectations of $44.20 billion. CVS Health Corp had a return on equity of 10.97% and a net margin of 2.16%. The company’s revenue was up 3.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.18 EPS. Equities analysts forecast that CVS Health Corp will post $5.87 EPS for the current year.

Several equities analysts have recently weighed in on the company. Tigress Financial assumed coverage on CVS Health Corp in a report on Thursday, April 27th. They set a “buy” rating on the stock. Vetr cut CVS Health Corp from a “buy” rating to a “hold” rating and set a $85.78 price objective on the stock. in a report on Thursday, April 27th. Bank of America Corp reiterated a “buy” rating and set a $106.67 price objective on shares of CVS Health Corp in a report on Tuesday, February 28th. Evercore ISI reiterated an “outperform” rating and set a $88.00 price objective (up previously from $87.00) on shares of CVS Health Corp in a report on Wednesday, May 3rd. Finally, Leerink Swann set a $90.00 target price on CVS Health Corp and gave the company a “buy” rating in a research note on Saturday, March 18th. Eight research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $94.39.

In related news, EVP Eva C. Boratto sold 6,029 shares of the firm’s stock in a transaction on Friday, March 17th. The stock was sold at an average price of $79.60, for a total value of $479,908.40. Following the transaction, the executive vice president now directly owns 41,614 shares of the company’s stock, valued at approximately $3,312,474.40. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP Troyen A. Brennan sold 23,849 shares of the firm’s stock in a transaction on Tuesday, March 21st. The stock was sold at an average price of $78.73, for a total value of $1,877,631.77. Following the completion of the transaction, the executive vice president now directly owns 94,309 shares in the company, valued at $7,424,947.57. The disclosure for this sale can be found here. Insiders have sold a total of 139,600 shares of company stock worth $11,205,962 over the last three months. Insiders own 0.58% of the company’s stock. CVS Health Corp Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “CVS”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS). Receive News & Ratings for CVS Health Corp Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CVS Health Corp and related companies with MarketBeat.com’s FREE daily email newsletter.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Related posts

Leave a Comment